Multiple Sclerosis
1 competing product in clinical development for Multiple Sclerosis.
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Duloxetine Hydrochloride (HCI) + Placebo | Eli Lilly | Phase 3 | Completed | 77 |
1 competing product in clinical development for Multiple Sclerosis.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Duloxetine Hydrochloride (HCI) + Placebo | Eli Lilly | Phase 3 | Completed | 77 |